João Alessi, MD, Dana-Farber Cancer Institute, Boston, MA, looks forward to learning more about how tumor microenvironments (TIMEs) can facilitate immunoresistance in novel immunotherapy treatments at SITC 2023, following his research in this field. This interview took place at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.